Posted inHealthcare Services
Paras Health IPO 2026: Price Band, Dates and How It Works
Paras Health IPO 2026 explained: dates, ₹660–₹693 price band, ₹500 crore fresh issue vs ₹950 crore offer for sale, and what to check.
Posted inLife Science
AI in Drug Development: Discovery vs Operations Explained
AI in drug development explained: how discovery tools differ from tools that coordinate trials and risk, after OpenAI’s Orchestra Bio deal.
Posted inHealthcare Services
Abuja Ebola Case Explained: Contact Tracing and Next Steps
Abuja Ebola case explained: what one imported infection means, how contact tracing of 44 people works, and what is still unknown.
Posted inPharmaceutical
Chronic Hepatitis B Treatment: What Hibsago Changes
Chronic hepatitis B treatment explained: who can use Hibsago, what trials showed on stopping medicine, and the boxed liver and platelet warning.
Posted inHealthcare IT
Facial Volume Loss After Weight Loss: What Experts Say
Facial volume loss after weight loss explained: why it happens on GLP-1 drugs, what creams and injectables can do, and what evidence exists.
Posted inPharmaceutical
Esophageal Cancer Immunotherapy Explained: What JUPITER-06 Shows
Esophageal cancer immunotherapy explained: how toripalimab works, what JUPITER-06 showed on survival and side effects, and what India’s approval means.
Posted inHealthcare Services
Third Measles Death US: Why CDC and State Counts Differ
Third measles death US reported by the CDC while Pennsylvania counts five. Why federal and state measles tallies differ, and how to read them.
Posted inPharmaceutical
Oral Inflammatory Bowel Disease Treatment: What Emvistegrast Shows
An oral inflammatory bowel disease treatment, emvistegrast, met its Phase 2 goal in ulcerative colitis. What the data show and cannot yet prove.
Posted inMedical Device
Vascular Closure Device Explained: What PerQseal Elite Changes
A vascular closure device seals the artery after catheter procedures. How Haemonetics’ PerQseal Elite patch works and what is still unproven.
Posted inLife Science
AI in Clinical Trials: Can AstraZeneca and Oracle Fix Slow Recruitment?
AI in clinical trials explained: how AstraZeneca and Oracle plan to speed patient recruitment and safety monitoring, and what is unproven.